ARTICLE | Company News
Quest Diagnostics sales and marketing update
December 18, 2006 8:00 AM UTC
DGX launched its Breast Cancer Gene Expression Ratio ( HOXB13:IL17BR) test to predict the risk of disease recurrence in women with estrogen receptor-positive, lymph node-negative breast cancer. The te...